Clinical Efficacy of Omidenepag Isopropyl for Primary Open-Angle Glaucoma, Normal Tension Glaucoma, or Ocular Hypertension: A Meta-Analysis
- 1 December 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 39 (10) , 705-715
Abstract
Purpose: To investigate the clinical efficacy of omidenepag isopropyl (OMDI) among glaucoma patients in terms of increased intraocular pressure (IOP) changes through a meta-analysis. Methods: Studies investigating the clinical efficacy of OMDI toward glaucoma patients were systemically searched. Inclusion criteria include recruiting studies that consisted of glaucoma or normal tension glaucoma patients who received OMDI treatment at least 4 weeks in duration. The primary outcome was to compare changes in IOP levels at baseline before OMDI treatment and after OMDI treatment. Results: Six studies were included with a total of 358 eyes. Our results showed OMDI monotherapy resulted in significant decreased IOP among patients with ocular hypertension, with weighted mean difference post-OMDI treatment being −4.684 (95% confidence interval: −6.010 to −3.358) and I2 of 91.092%. Separate subgroup analyses also showed initial IOP greater than 21 mmHg and those within the age group greater than 65 years old to be correlated with significant reduction in IOP post-OMDI. Randomized control trial (RCTs) design was also found to be superior compared with non-RCT in terms of investigating IOP changes after OMDI. The country of origin of the recruited studies and OMDI dosage frequencies were also found to have no effect on overall IOP changes after OMDI treatment. Conclusions: The current meta-analysis indicates OMDI to be a clinically effective treatment for glaucoma patients in terms of lowering IOP levels.Keywords
This publication has 33 references indexed in Scilit:
- Update on the Medical Treatment of Primary Open-Angle GlaucomaAsia-Pacific Journal of Ophthalmology, 2016
- Comparative Effectiveness of First-Line Medications for Primary Open-Angle GlaucomaOphthalmology, 2016
- Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous ThromboembolismThe Patient - Patient-Centered Outcomes Research, 2013
- Key Needs and Opportunities for Treating GlaucomaInvestigative Ophthalmology & Visual Science, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative eraFertility and Sterility, 2009
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Update on the Mechanism of Action of Topical Prostaglandins for Intraocular Pressure ReductionSurvey of Ophthalmology, 2008
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Glaucoma MedicationsDrugs & Aging, 2006